Aura Biosciences, Inc. Contracts & Agreements
31 Contracts & Agreements
- Business Finance (7 contracts)
- Business Operations (1)
- Human Resources (17)
- Intellectual Property (3)
- Real Estate (1)
- Uncategorized (2)
- Transition and Release Agreement, dated September 25, 2024, by and between Julie Feder and the Registrant (Filed With SEC on November 12, 2024)
- Resignation and Consulting Agreement, dated September 25, 2024, by and between Julie Feder and the Registrant (Filed With SEC on November 12, 2024)
- Executive Severance Plan, and form of participation agreement thereunder (Filed With SEC on November 12, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 8, 2024)
- Employment Offer Letter, dated March 12, 2024, by and between Conor Kilroy and the Registrant (Filed With SEC on May 9, 2024)
- Description of Securities (Filed With SEC on March 27, 2024)
- Employment Offer Letter, dated August 10, 2023, by and between Mark Plavsic and the Registrant (Filed With SEC on March 27, 2024)
- Employment Offer Letter, dated August 9, 2023, by and between Jill Hopkins and the Registrant (Filed With SEC on November 9, 2023)
- Transition and Release Agreement, dated September 28, 2023, by and between Cadmus Rich and the Registrant (Filed With SEC on November 9, 2023)
- Consulting Agreement, dated September 28, 2023, by and between Cadmus Rich and the Registrant (Filed With SEC on November 9, 2023)
- Transition and Release Agreement, dated November 6, 2023, by and between Cadmus Rich and the Registrant (Filed With SEC on November 9, 2023)
- Underwriting Agreement, dated as of November 6, 2023, by and between the Company, Leerink Partners, Cowen and Evercore ISI, as representatives of the several underwriters named... (Filed With SEC on November 9, 2023)
- Underwriting Agreement, dated as of November 30, 2022, by and between the Company, SVB Securities, Cowen and Evercore ISI, as representatives of the several underwriters named... (Filed With SEC on December 5, 2022)
- Description of Securities (Filed With SEC on March 23, 2022)
- Form of Underwriting Agreement (Filed With SEC on October 25, 2021)
- Specimen Common Stock Certificate (Filed With SEC on October 25, 2021)
- 2021 Stock Option and Incentive Plan, and form of award agreements thereunder (Filed With SEC on October 25, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on October 25, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on October 25, 2021)
- Senior Executive Cash Bonus Plan (Filed With SEC on October 25, 2021)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on October 25, 2021)
- Employment Agreement between the Registrant and Elisabet de los Pinos, dated January 1, 2015, as amended on October 13, 2017 (Filed With SEC on October 25, 2021)
- Employment Offer Letter between the Registrant and Julie Feder, dated August 10, 2018 (Filed With SEC on October 25, 2021)
- Employment Offer Letter between the Registrant and Cadmus Rich, dated October 14, 2017 (Filed With SEC on October 25, 2021)
- Fifth Amended and Restated Investors Rights Agreement (Filed With SEC on October 8, 2021)
- 2009 Amended and Restated Stock Option and Restricted Stock Plan, and form of award agreements thereunder (Filed With SEC on October 8, 2021)
- 2018 Equity Incentive Plan, and form of award agreements thereunder (Filed With SEC on October 8, 2021)
- Exclusive Patent License Agreement with the National Institutes of Health, dated September 3, 2013 as amended (Filed With SEC on October 8, 2021)
- Exclusive License and Supply Agreement with LI-COR, Inc., dated January 31, 2014, as amended (Filed With SEC on October 8, 2021)
- License Agreement with Clearside Biomedical, Inc., dated July 3, 2019 (Filed With SEC on October 8, 2021)
- Lease Agreement with Bolton Street Partners, LLC, dated June 9, 2011, as amended (Filed With SEC on October 8, 2021)
